Spectrum is committed to ongoing research and development into the therapeutic efficacy and safety of medical cannabis

Research Studies Worldwide

For over 40 years, scientists and clinicians have studied the therapeutic efficacy of cannabis, its extracts, and refined phytochemicals.

There are 400+ clinical studies in place around the globe
245 United States
45 Europe
32 Canada
25 Israel
4 Latin America
3 Australia

*Source: US National Library of Medicine. Last updated June 2018.

Research at Spectrum Therapeutics

Spectrum Therapeutics is a biopharmaceutical company researching the therapeutic effects and safety profiles of innovative cannabis-based medicines to create a range of effective formulations and delivery mechanisms.


We aim to leverage this R&D to improve the quality of life and health of those suffering from acute and chronic illnesses worldwide.

Research Applications

Through our research programs, the aim is to create natural plant-based medicines and health products derived from cannabis to improve the quality of life for those affected by acute and chronic illness. We support applicants who are rigorous with their research and committed to advancing cannabinoid science.


Due to the large number of research requests that we have received, we regret that we are not accepting new research requests at this time. Please check back with us for future research requests.

This website uses cookies to recognize your computer or device to give you the best user experience and to improve its features. You can disable cookies through your browser but some features of the site will no longer be available. To read our Website Privacy Statement, click here.